Exploration of optimal time for initiating adjuvant chemotherapy after surgical resection: A retrospective study in Chinese patients with stage IIIA non‐small cell lung cancer in a single center

BACKGROUND: Adjuvant chemotherapy (ACT) can reduce the risk of recurrence and improve survival after surgical resection in non‐small cell lung cancer (NSCLC) patients. We explore the optimal time from surgery to initiation of ACT in Chinese patients with stage IIIA NSCLC. METHODS: Patients pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yixiang, Zhai, Xiaoyu, Chen, Sipeng, Wang, Ziping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930958/
https://www.ncbi.nlm.nih.gov/pubmed/27385981
http://dx.doi.org/10.1111/1759-7714.12342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930958/
https://www.ncbi.nlm.nih.gov/pubmed/27385981
http://dx.doi.org/10.1111/1759-7714.12342

Ejemplares similares